News in brief: Rua’s German stock shortage; Zelira’s finance deal; cultivator nets $1.4m; Neurotech exec steps down; ‘major milestone’ for Argent; Cann Group pharmacy deal by Steve Jones and Martin Lane April 3, 2025April 3, 2025 Rua Bioscience said it delivered record sales in March despite a supply shortage impacting sales in […]
Company news: GrowerIQ; Neurotech International; Medical Kiwi by Martin Lane February 4, 2025February 4, 2025
Neurotech seeks pharma partners for overseas drug development but will go it alone in Australia by Steve Jones August 12, 2024August 12, 2024
Neurotech reports strong trial results as firm raises A$10m to fund drug-registration activities by Steve Jones April 17, 2024April 18, 2024
Neurotech progresses ASD trial, inks deal with contract research organisation by Martin Lane April 10, 2024July 16, 2024
Company news: Cann Global; Cann Group; InhaleRx; AusCann; Wellnex Life; Neurotech; MGC Pharma; Stenocare by Martin Lane December 4, 2023April 30, 2024
Company news: Emyria; Wellnex Life; Neurotech International; Melodiol Global Health by Martin Lane November 14, 2023April 30, 2024
Company news: MGC Pharma; Neurotech International; Incannex Healthcare by Martin Lane June 1, 2023April 30, 2024
Company news: Althea; Cann Group; Emyria; Neurotech; Bod Science; Elixinol; Creso Pharma; MGC Pharma by Steve Jones and Martin Lane January 31, 2023February 2, 2023
